Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

11.18

+0.36 (3.33%)

At close: Aug 13, 2025, 4:00 PM

11.14

-0.04 (-0.36%)

Pre-market: Aug 14, 2025, 8:40 AM EDT

Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $3.77 billion as of August 14, 2025. Its market cap has decreased by -8.26% in one year.

Market Cap

3.77B

Enterprise Value

3.69B

1-Year Change

-8.26%

Ranking

#1527

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.77B, an increase of 3,170.30%. That is a compound annual growth rate of 56.82%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	3.77B	-26.05%
Dec 31, 2024	5.10B	129.18%
Dec 29, 2023	2.22B	42.30%
Dec 30, 2022	1.56B	-2.70%
Dec 31, 2021	1.61B	96.45%
Dec 31, 2020	817.72M	196.48%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	570.26B
Johnson & Johnson	418.62B
AbbVie	350.91B
AstraZeneca	229.47B
UnitedHealth Group	228.94B
Novartis AG	228.69B
Abbott Laboratories	228.63B
Novo Nordisk	222.88B

Market Cap Rankings